The voluntary recall affects the 75-mg dose of dabigatran (lot 201900). There are concerns about a manufacturing defect that might affect the integrity of the medication bottles.
News Alerts
via Medscape news
News Alerts
via Medscape news
The India Cardiology 2.0 Medical Social Media Network
No comments:
Post a Comment